Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018
Apr 27, 2018 05:34 am UTC| Business
Company announcement - No. 13/2018 Zealand announces net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® for the first quarter of 2018 Net sales of Soliqua® 100/33 and Lyxumia®/Adlyxin® of EUR 14.5 million/USD...
Sanofi: First-quarter 2018 Business EPS(1) up 1.4% at CER
Apr 27, 2018 05:32 am UTC| Business
Paris, April 27, 2018 First-quarter 2018 Business EPS(1) up 1.4% at CER Q1 2018 Change Change at CER IFRS net sales reported €7,898m -8.7% -0.4% IFRS net ...
DBV Technologies Reports March 31, 2018 Cash Position
Apr 27, 2018 05:31 am UTC| Business
Montrouge, France, April 27, 2018 DBV Technologies Reports March 31, 2018 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and cash...
REXEL : FIRST-QUARTER 2018 RESULTS
Apr 27, 2018 05:31 am UTC| Business
FIRST-QUARTER 2018 RESULTS (unaudited) Q1 18 IN LINE WITH OUR EXPECTATIONS SAME-DAY SALES UP 3.9% AND STABLE RECURRING NET INCOME IMPROVED FREE CASH FLOW - SALES OF €3.178bn IN Q1, UP IN EVERY GEOGRAPHY...
Apr 27, 2018 05:31 am UTC| Business
Mechelen, Belgium; 27 April 2018, 7.30 CET - Galapagos NV (Euronext NASDAQ: GLPG) presents preclinical results showing broad beneficial effects on cartilage and bone with GLPG1972 in an osteoarthritis (OA) rat model at...
CNH Industrial N.V. new buyback program
Apr 27, 2018 05:30 am UTC| Business
London, April 27, 2018 CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) advises its intention to issue its new shares buyback program (the "Program"). The Program will involve the repurchase from time to time of up to $700...
Apr 27, 2018 05:30 am UTC| Business
Press release Leuven, Belgium, April 27 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfully enrolled the...